Cargando…
Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations
OBJECTIVES: The rapid discovery of clinically significant genetic variants has translated to next-generation sequencing assays becoming out-of-date by the time they are designed, validated, and implemented. UW-OncoPlex addresses this through the adoption of a modular panel capable of redesign as sig...
Autores principales: | Kuo, Ayako J., Paulson, Vera A., Hempelmann, Jennifer A., Beightol, Mallory, Todhunter, Sheena, Colbert, Brice G., Salipante, Stephen J., Konnick, Eric Q., Pritchard, Colin C., Lockwood, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038441/ https://www.ncbi.nlm.nih.gov/pubmed/32123717 http://dx.doi.org/10.1016/j.plabm.2020.e00153 |
Ejemplares similares
-
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
por: Hempelmann, Jennifer A., et al.
Publicado: (2018) -
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference
por: Jensen, Kendal, et al.
Publicado: (2020) -
Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
por: Bosch, Dustin E., et al.
Publicado: (2022) -
Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
por: Konnick, Eric Q., et al.
Publicado: (2016) -
The regulatory landscape of precision oncology laboratory medicine in the United States – Perspective on the past 5 years and considerations for future regulation
por: Konnick, Eric Q.
Publicado: (2020)